Allenex AB: University of Miami Initiates Clinical Trial of XM-ONE® Business Wire (press release) “Non-HLA antibodies, especially endothelial cell antibodies, play a significant role as risk markers of acute rejection in kidney transplant recipients” says Dr. Giselle Guerra, MD at the University of Miami and principal investigator of the study. |
